AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 161 min read$SNPS

Ghazi Sassine sold $6.8M of SNPS

Ghazi Sassine (PRESIDENT AND CEO) sold 14,604 shares of SYNOPSYS INC (SNPS) at $462.84 ($6.76M total) on 2026-10-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Ghazi Sassine
Published Oct 16, 2026, 9:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 9:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$SNPS
Bearish
medium confidence
Mentioned
$SNPS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider sentiment, which can influence short‑term price dynamics.

02

Market read

The filing adds a new data point for SNPS investors, offering a modest trading cue.

03

What to watch

Potential tax planning or liquidity needs for the CEO; not necessarily a bearish indicator.

Relevance 5/10Novelty 6/10Timing: today

Background

Form 4 filings disclose insider transactions; a CEO sale is closely watched by market participants.

Company-level read

Ticker impact

$SNPSBearishMedium confidence
Context

CEO Ghazi Sassine sold 14,604 shares for $6.76M via a 10b5‑1 plan, reducing his stake to 76,865 shares.

Expected impact

likely downward pressure as the market prices the insider sale

Evidence & confidence

The sale size is modest relative to market cap but involves the CEO, which traders often view as a negative signal.

Market effects

Sector

Minimal impact on the broader software sector; the sale is company‑specific.

Regional

No regional effect beyond investor sentiment on SNPS.

Global

Limited to investors tracking insider activity in large‑cap tech stocks.

Counterpoint

What could challenge this read

The sale could be a routine portfolio adjustment unrelated to company fundamentals.

Key entities

  • person
    Ghazi Sassine

    President and CEO of Synopsys Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SNPS insider trading history →

Related articles

OCT 27
$SNPSMed

Why Should You Think About Synopsys Differently Now?

Synopsys (SNPS) trades at 80.8x P/E, focusing on AI-driven chip design and Ansys. Its IP business, which underperformed due to export restrictions and customer challenges, returned to growth in Q3 2026. Ansys revenue was 1.5x Design IP's revenue in the same quarter. Management highlights a shift to a licensing-plus-royalties model, with a $1B+ deal with Amazon.

finance.yahoo.com2 min
OCT 26
$SNPSMed

S&P lifts Synopsys to ’BBB+’ as chip-design leader capitalizes on AI demand

S&P Global Ratings upgraded Synopsys Inc's credit rating to 'BBB+' from 'BBB', citing strong long-term growth prospects driven by AI demand. The company expects mid-teens revenue growth through 2029 and improved profitability, with 2029 EBITDA margin projected at 49%. Synopsys is also accelerating cost synergies from its Ansys acquisition and expanding commercial traction, including a $1B+ contract with Amazon.

investing.com2 min
OCT 22
$AMZNMedAI 8/10

Amazon and Synopsys seal $1bn technology partnership

Amazon and Synopsys have signed a $1 billion deal to accelerate Amazon's custom silicon innovation and advance AI products and cloud infrastructure. The multi-year agreement builds on 15 years of collaboration, with Synopsys providing application-optimized silicon IP. Amazon's Peter DeSantis highlighted the impact of custom silicon on AWS, while Synopsys' Sassine Ghazi emphasized the partnership's role in shaping AI-native engineering.

echo.ie2 min
OCT 20
$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.

finimize.com2 min